CRISPR Used to Develop Low Glutelin Rice for Phenylketonuria and Kidney Disease PatientsSeptember 14, 2022
Researchers from Jiangsu Academy of Agricultural Sciences and Yangzhou University in China developed low glutelin rice using the CRISPR-Cas9 gene editing system. Their findings are published in Plant Science.
Chronic kidney disease and phenylketonuria patients are required to consume rice with low glutelin content. Thus, one of the goals of rice breeders is to come up with high-yielding rice varieties with low glutelin and delicious taste.
The research team used CRISPR-Cas9 to simultaneously edit up to 7 genes involved in the production of glutelin in rice. Results showed that two out of the nine edited lines had significantly lower glutelin content, which is even reduced than low glutelin content cultivar LGC-1. These two lines also have similar agronomic characteristics and viscosity properties as the wild-type, indicating their potential as new varieties or parental materials for breeding low glutelin rice.
Read the research article in Plant Science.
You might also like:
- Pocket K No. 54: Plant Breeding Innovation: CRISPR-Cas9
- Heat-Moisture Treatment Improves Starch Content of Healthy Rice
- Researchers Use CRISPR Technology to Treat Beta Thalassemia Patients
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- What do you think of this newsletter?
- Nigeria Adopts Guidelines on GM Plants with Stacked Genes
- Researchers Unearth Genome of Wild Shrub from Tomato Family
- US Launches National Biotechnology and Biomanufacturing Initiative
- Canada's Guidelines on Gene Editing to Advance Innovation
- GM Purple Tomato Gets Approval in the United States
- Vietnam’s Animal Biotech Research Capability to Support Gov’t’s Agricultural and Environmental Sustainability Goals
- Asian Regional Workshop on Current and Upcoming Items under the CBD and its Protocols
- Study Reveals Role of CW198 in Enhancer-promoter Interaction in Plants
Plant Breeding Innovations
- BREEDIT Bridges Gap Between Conventional Breeding and Gene Editing Techniques
- Specialty Crops to Hit the Market as First Gene-edited Entrants
- CRISPR Used to Develop Low Glutelin Rice for Phenylketonuria and Kidney Disease Patients
Read the latest:
- Crop Biotech Update (December 1, 2022)
- Genome Editing Supplement (November 23, 2022)
- Gene Drive Supplement (December 1, 2022)
Subscribe to CBU: